The American Society of Clinical Psychopharmacology (ASCP) was founded in 1992 to advance the science and practice of clinical psychopharmacology. Its over 900 members are physicians who study and practice psychopharmacology, as well as doctoral level investigators of clinical psychopharmacology or of pharmacology. ASCP members are advocates for clinical psychopharmacology and for clinical research.

ASCP has over 900 members, most of whom live in the United States. It is headquartered in Brentwood, Tennessee.

The Society has three major meetings per year. The Fall and Spring Update on Psychopharmacology: State of the Art meetings (East and West coast) brings together a number of outstanding psychopharmacologists to speak and dialogue with meeting participants. For over 50 years, the ASCP Annual Meeting (formerly known as NCDEU) has featured emerging research in the field of psychopharmacology and brings together over 900 academic and industry investigators, research pharmacists, and clinicians.

ASCP's official journal is The Journal of Clinical Psychiatry, with the largest circulation in psychiatry.

Because education is a primary focus of the society, ASCP has developed a Model Curriculum in Psychopharmacology for Psychiatry Residency Training. The Curriculum is now in its 10th edition, and is widely used in the United States and internationally.  A joint version for medical student educators and a primary care version were recently released.

ASCP invites you to learn more about our Society and programs by exploring this web site, and invites you to attend one or more of our excellent meetings.

ASCP is a proud member of the American Brain Coalition (ABC).